Mills Biopharmaceuticals Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Mills Biopharmaceuticals General Information

Description

Provider of brachytherapy treatment services. The company is engaged in supplying of Iodine 125 and Palladium Pd-103 seeds for low dose prostate brachytherapy treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 120 NorthEast 26th Street
  • Oklahoma City, OK 73105
  • United States
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Drug Delivery
Acquirer
Core Oncology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 120 NorthEast 26th Street
  • Oklahoma City, OK 73105
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mills Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request a free trial

Mills Biopharmaceuticals Patents

  • 62

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 24

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Mills Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2005333220-A1 Radiation shielding device Inactive 13-Aug-2004 0000000000
CA-2577298-A1 Radiation shielding device Inactive 13-Aug-2004 0000000000
EP-1819398-A2 Radiation shielding device Inactive 13-Aug-2004 0000000000 0
US-7425195-B2 Radiation shielding device Inactive 13-Aug-2004 0000000000 0
US-20060063960-A1 Radiation shielding device Active 13-Aug-2004 A61N5/1027 0
To view Mills Biopharmaceuticals’s complete patent history, request access »

Mills Biopharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mills Biopharmaceuticals‘s full profile, request access.

Request a free trial

Mills Biopharmaceuticals FAQs

  • When was Mills Biopharmaceuticals founded?

    Mills Biopharmaceuticals was founded in 1992.

  • Who is the founder of Mills Biopharmaceuticals?

    Stanley Mills is the founder of Mills Biopharmaceuticals.

  • Where is Mills Biopharmaceuticals headquartered?

    Mills Biopharmaceuticals is headquartered in Oklahoma City, OK.

  • What industry is Mills Biopharmaceuticals in?

    Mills Biopharmaceuticals’s primary industry is Other Healthcare Services.

  • Is Mills Biopharmaceuticals a private or public company?

    Mills Biopharmaceuticals is a Private company.

  • What is Mills Biopharmaceuticals’s current revenue?

    The current revenue for Mills Biopharmaceuticals is 000000.

  • Who are Mills Biopharmaceuticals’s investors?

    Coloplast, Mentor Worldwide, and UroCor Labs have invested in Mills Biopharmaceuticals.

  • When was Mills Biopharmaceuticals acquired?

    Mills Biopharmaceuticals was acquired on 12-Jun-2007.

  • Who acquired Mills Biopharmaceuticals?

    Mills Biopharmaceuticals was acquired by Core Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »